4016 fundamentals
An in-depth look to MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. operating, investing, and financing activities
4016 free cash flow for Q3 24 is -32.17 M SAR. For 2023, 4016 free cash flow was 67.49 M SAR and operating cash flow was 88.33 M SAR.
Q2 '22
Q2 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SAR
Q2 '22
Q2 '23
Q1 '24
Q2 '24
Q3 '24
TTM